Showing results (101-110 of 354) with videos related to

Sort By:
Pageof 36
Seminars in Oncology|November 23, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. OncologyEdward T H Yeh, Michael S Ewer, Javid Moslehi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2014
Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: a comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac eventsMichael S Ewer, Thomas M Suter, Daniel J Lenihan, et al.
World Journal of Urology|May 21, 2003
The selenium and vitamin E cancer prevention trialEric A Klein, Scott M Lippman, Ian M Thompson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 7, 2002
Her-2/neu gene amplification in ductal carcinoma in situ of the breastAshraful Hoque, Nour Sneige, Aysegul A Sahin, et al.
The Journal of Biological Chemistry|January 3, 2023
Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitryNadia Arang, Simone Lubrano, Damiano Cosimo Rigiracciolo, et al.
Cancer Research|February 28, 2002
GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Susan M Fischer, et al.
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
Carcinogenesis|June 6, 2012
Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskJie Lin, Charles Lu, David J Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatmentMichael S Ewer, Mary T Vooletich, Jean-Bernard Durand, et al.
The Journal of Biological Chemistry|August 6, 2003
Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nucleiThomas R Salas, Shrikanth A Reddy, John L Clifford, et al.
Pageof 36